Emmanuel J. Favaloro: New Research Highlights Benchmarks for Low Molecular Weight Heparin Monitoring
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis at Westmead Hospital, Editor in Chief of Seminars in Thrombosis and Hemostasis, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Seminars in Thrombosis and Hemostasis, adding:
“Latest publication from the Sydney Centres for Thrombosis and Haemostasis.
This one in collaboration with the Royal College of Pathologists of Australasia (RCPA) Quality Assurance Program (QAP) Haematology.”
Title: External Quality Assessment for Low Molecular Weight Heparin Monitoring in the Australasia|Asia-Pacific Region
Authors: Emmanuel J. Favaloro, Sandya Arunachalam, Leonardo Pasalic
Other posts featuring Emmanuel J Favalaro on Hemostasis Today.
-
Jul 4, 2026, 15:38Roshni Kulkarni: Maternal Mortality In Bleeding Disorders
-
Jul 4, 2026, 15:34Alejandro González Veliz: Does Elevated Lp(a) Always Mean the Same Cardiovascular Risk?
-
Jul 4, 2026, 15:20Bruno Pougault: Heparin Monitoring Remains One of the Most Challenging Areas in Laboratory Hemostasis
-
Jul 4, 2026, 15:12Rethinking Stroke Prevention – New Frontiers in Minimizing Bleeding Concerns – ISTH
-
Jul 4, 2026, 14:40Liver Cirrhosis and Portal Vein Thrombosis: Understanding a Critical Complication
-
Jul 4, 2026, 14:40Debra Bellon: A Milestone for Global Rare Disease Advocacy in Nairobi
-
Jul 4, 2026, 14:11Erica Wood: Next Webinar from the Optimal Centre of Research Excellence on Improving Immunoglobulin Use
-
Jul 4, 2026, 14:07Ariela Marshall: Optimizing Inpatient Hematology Consult Services Through Best Practices And Strategy
-
Jul 4, 2026, 13:53Azusa Nagao: Why Is von Willebrand Disease Still Being Missed in Japan?